109 related articles for article (PubMed ID: 14641813)
21. Influence of N-(o-methoxyphenyl)-maleimide on 5-fluorouracil cytotoxicity in Ehrlich (ascites) carcinoma.
Ambaye RY; Indap MA
Cancer Lett; 1991 Apr; 57(1):21-6. PubMed ID: 1902758
[TBL] [Abstract][Full Text] [Related]
22. Antitumor activity and antioxidant status of Caesalpinia bonducella against Ehrlich ascites carcinoma in Swiss albino mice.
Gupta M; Mazumder UK; Kumar RS; Sivakumar T; Vamsi ML
J Pharmacol Sci; 2004 Feb; 94(2):177-84. PubMed ID: 14978356
[TBL] [Abstract][Full Text] [Related]
23. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice.
Bhattacharya S; Prasanna A; Majumdar P; Kumar RB; Haldar PK
Pharm Biol; 2011 Sep; 49(9):927-35. PubMed ID: 21819262
[TBL] [Abstract][Full Text] [Related]
24. Induction of developmental toxicity in mice treated with Alstonia scholaris (Sapthaparna) In utero.
Jagetia GC; Baliga MS
Birth Defects Res B Dev Reprod Toxicol; 2003 Dec; 68(6):472-8. PubMed ID: 14745981
[TBL] [Abstract][Full Text] [Related]
25. Antioxidant and anticarcinogenic effects of methanolic extract and volatile oil of fennel seeds (Foeniculum vulgare).
Mohamad RH; El-Bastawesy AM; Abdel-Monem MG; Noor AM; Al-Mehdar HA; Sharawy SM; El-Merzabani MM
J Med Food; 2011 Sep; 14(9):986-1001. PubMed ID: 21812646
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo.
Mourelatos D; Dozi-Vassiliades J; Kotsis A; Gourtsas C
Cancer Res; 1988 Mar; 48(5):1129-31. PubMed ID: 3342394
[TBL] [Abstract][Full Text] [Related]
27. Antineoplastic activity of N-(2-hydroxybenzylidene)2'-hydroxyphenylimine aqua nickel(II) complex [NI(H₂O)HHP] on ehrlich ascites carcinoma (EAC) in Swiss albino mice.
Hossain IA; Khanam JA; Jesmin M; Ali MM
Exp Toxicol Pathol; 2016 Jan; 68(1):15-25. PubMed ID: 26404919
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of radiation effect by Aphanamixis polystachya in mice transplanted with Ehrlich ascites carcinoma.
Jagetia GC; Venkatesha VA
Biol Pharm Bull; 2005 Jan; 28(1):69-77. PubMed ID: 15635166
[TBL] [Abstract][Full Text] [Related]
29. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Ganguly A; Chakraborty P; Banerjee K; Chatterjee S; Basu S; Sarkar A; Chatterjee M; Choudhuri SK
Biometals; 2012 Feb; 25(1):149-63. PubMed ID: 21915630
[TBL] [Abstract][Full Text] [Related]
30. Influence of anethole treatment on the tumour induced by Ehrlich ascites carcinoma cells in paw of Swiss albino mice.
al-Harbi MM; Qureshi S; Raza M; Ahmed MM; Giangreco AB; Shah AH
Eur J Cancer Prev; 1995 Aug; 4(4):307-18. PubMed ID: 7549823
[TBL] [Abstract][Full Text] [Related]
31. Terpenoids of methanol extract of Clerodendrum infortunatum exhibit anticancer activity against Ehrlich's ascites carcinoma (EAC) in mice.
Sannigrahi S; Mazumder UK; Pal D; Mishra SL
Pharm Biol; 2012 Mar; 50(3):304-9. PubMed ID: 22321031
[TBL] [Abstract][Full Text] [Related]
32. Amelioration effect of Egyptian sweet orange hesperidin on Ehrlich ascites carcinoma (EAC) bearing mice.
Donia TIK; Gerges MN; Mohamed TM
Chem Biol Interact; 2018 Apr; 285():76-84. PubMed ID: 29481770
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of anticancer activity of ethanol extract of Sesbania grandiflora (Agati Sesban) against Ehrlich ascites carcinoma in Swiss albino mice.
Sreelatha S; Padma PR; Umasankari E
J Ethnopharmacol; 2011 Apr; 134(3):984-7. PubMed ID: 21251969
[TBL] [Abstract][Full Text] [Related]
34. C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice.
Bevara GB; Kumar ADN; Koteswramma K L; Badana AK; Kumari S; Yarla NS; Malla RR
Anticancer Agents Med Chem; 2017; 17(9):1256-1266. PubMed ID: 28044935
[TBL] [Abstract][Full Text] [Related]
35. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Majumder S; Dutta P; Mookerjee A; Choudhuri SK
Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
[TBL] [Abstract][Full Text] [Related]
36. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
Holm B; Jensen PB; Sehested M
Cancer Chemother Pharmacol; 1996; 38(3):203-9. PubMed ID: 8646793
[TBL] [Abstract][Full Text] [Related]
37. Enhancing effect of new biological response modifier sulfoethylated (1-->3)-beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses.
Khalikova TA; Korolenko TA; Zhanaeva SY; Kaledin VI; Kogan G
Exp Oncol; 2006 Dec; 28(4):308-13. PubMed ID: 17285116
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic activity of pretazettine on Ehrlich ascites carcinoma: adjuvant effect on standard drugs in ABC regimen.
Furusawa E; Lum MK; Furusawa S
Chemotherapy; 1981; 27(4):277-86. PubMed ID: 7249790
[TBL] [Abstract][Full Text] [Related]
39. Cytocidal and toxic effect of various cytostatic drugs on three ascites tumors of the mouse.
Schäfer E; Maurer-Schultze B
J Cancer Res Clin Oncol; 1987; 113(3):216-22. PubMed ID: 3584212
[TBL] [Abstract][Full Text] [Related]
40. Effects of alkylating antineoplastics alone or in combination with 3-aminobenzamide on genotoxicity, antitumor activity, and NAD levels in human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo.
Petrou C; Mourelatos D; Mioglou E; Dozi-Vassiliades J; Catsoulacos P
Teratog Carcinog Mutagen; 1990; 10(4):321-31. PubMed ID: 1980034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
